Krsnaa Diagnostics Share Price

Overview
Recos
News
Analysis
Financials
Forecast
Technicals
Peers
Shareholdings
MF
F&O
Corp Actions
About

Krsnaa Diagnostics Share Price

533.10-1.70 (-0.32%)

Closed
As On: 11 Jun, 2026, 03:57 PM IST
As On: 11 Jun, 2026, 03:40 PM IST

Sector: Hospitals & All...
Industry: Diagnostics

1D
1W
1M
3M
6M
1Y
5Y

Loading...

Try ETMarkets GPTNEW

Open	534.80
High	543.45
Low	531.00
Prev Close	534.80
Volume	42,620
VWAP(₹)	536.87

Key Metrics

PE Ratio(x)	17.05
EPS - TTM(₹)	31.27
MCap(₹ Cr.)	1,729.31
MCap Rank	26
PB Ratio(x)	1.77
Div Yield(%)	-
Face Value(₹)	5.00
52W High(₹)	894.40
52W Low(₹)	515.00
MCap/Sales	2.19
Beta(1 Month)	-
BV/Share(₹)	302.23

Krsnaa Diagnostics share price insights

Quarterly Topline Performance
Company witnessed QoQ revenue growth of 21.16%, which is highest in the last 3 years. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent 4.45% of its operating revenues towards interest expenses and 18.18% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
Krsnaa Diagnostics Share Price Update
Krsnaa Diagnostics Ltd. share price moved down by -0.32% from its previous close of Rs 534.80. Krsnaa Diagnostics Ltd. stock last traded price is 533.10
Share Price Value
Today/Current/Last 533.10531.00
Previous Day 534.80535.35

Found Insights useful?

Krsnaa Diagnostics Share Price Returns

1 Day	-0.32%
1 Month	-9.78%
3 Months	-13.93%
1 Year	-22.36%
3 Years	-5.9%
5 Years	N.A.

Krsnaa Diagnostics Share Recommendations

Mean recosCurrent

BUY

3 Analysts

Strong
SellSellHoldBuyStrong
Buy

Analyst Trends

Ratings	Current	1W Ago	1M Ago	3M Ago
Strong Buy	1	1	1	1
Buy	1	1	-	1
Hold	-	-	-	-
Sell	1	1	1	1
Strong Sell	-	-	-	-
# Analysts	3	3	2	3

Recent Recos

Target₹1010
OrganizationJM Financial
BUY

Target₹1050
OrganizationJM Financial
BUY

Target₹840
OrganizationJM Financial
BUY

View all Stock Recommendations

News & Analysis

View all Krsnaa Diagnostics Share News & Announcements

Share Analysis

EARNINGS

FUNDAMENTAL

RELATIVE VALUATION

RISK

PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

Score on 10-point scale
Ratings by analysts
Stock performance

JOIN ET PRIME

Financials

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	224.10	184.97	210.16	196.93	190.46
Total Income Growth (%)	21.16	-11.99	6.72	3.39	3.65
Total Expenses	160.31	157.42	170.42	163.21	155.05
Total Expenses Growth (%)	1.84	-7.63	4.42	5.27	1.91
EBIT	63.79	27.55	39.74	33.71	35.42
EBIT Growth (%)	131.51	-30.67	17.88	-4.81	12.04
Profit after Tax (PAT)	41.72	15.25	23.95	20.52	20.68
PAT Growth (%)	173.63	-36.33	16.69	-0.76	6.51
EBIT Margin (%)	28.46	14.90	18.91	17.12	18.60
Net Profit Margin (%)	18.62	8.24	11.39	10.42	10.86
Basic EPS (₹)	12.86	4.72	7.38	6.35	6.40

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Income	204.42	163.23	187.10	179.61	179.11
Total Income Growth (%)	25.24	-12.76	4.17	0.28	2.67
Total Expenses	138.44	134.29	148.34	147.03	143.15
Total Expenses Growth (%)	3.09	-9.47	0.89	2.71	2.28
EBIT	65.99	28.94	38.75	32.58	35.96
EBIT Growth (%)	128.02	-25.32	18.94	-9.39	4.25
Profit after Tax (PAT)	43.38	16.49	23.24	19.56	21.07
PAT Growth (%)	163.05	-29.03	18.80	-7.14	-2.48
EBIT Margin (%)	32.28	17.73	20.71	18.14	20.08
Net Profit Margin (%)	21.22	10.10	12.42	10.89	11.76
Basic EPS (₹)	13.37	5.08	7.12	6.10	6.52

	FY 2026	FY 2025	FY 2024	FY 2023
Total Revenue	816.16	742.70	636.43	506.50
Total Revenue Growth (%)	9.89	16.70	25.65	7.68
Total Expenses	685.73	640.01	566.42	426.30
Total Expenses Growth (%)	7.14	12.99	32.87	11.06
Profit after Tax (PAT)	101.43	77.61	56.84	62.11
PAT Growth (%)	30.70	36.54	-8.49	-9.18
Operating Profit Margin (%)	21.32	17.75	13.95	18.04
Net Profit Margin (%)	13.12	10.82	9.17	12.75
Basic EPS (₹)	31.29	24.04	17.90	19.78

	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	734.36	707.36	606.82	483.49	469.82
Total Revenue Growth (%)	3.82	16.57	25.51	2.91	-28.97
Total Expenses	602.04	597.76	534.87	401.30	380.22
Total Expenses Growth (%)	0.72	11.76	33.28	5.55	3.88
Profit after Tax (PAT)	102.68	82.81	58.56	63.51	70.70
PAT Growth (%)	23.99	41.40	-7.79	-10.17	-61.77
Operating Profit Margin (%)	24.06	19.68	14.98	19.36	23.76
Net Profit Margin (%)	14.86	12.14	9.92	13.68	15.54
Basic EPS (₹)	31.69	25.65	18.45	20.23	23.66

All figures in Rs Cr, unless mentioned otherwise

Insights

Quarterly Topline Performance
Company witnessed QoQ revenue growth of 21.16%, which is highest in the last 3 years. (Source: Consolidated Financials)
Employee & Interest Expense
Company has spent 4.45% of its operating revenues towards interest expenses and 18.18% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)

Annual	FY 2026	FY 2025	FY 2024	FY 2023
Total Assets	1,823.72	1,281.60	1,171.91	909.89
Total Assets Growth (%)	42.30	9.36	28.80	3.85
Total Liabilities	843.33	398.83	362.11	171.16
Total Liabilities Growth (%)	111.45	10.14	111.57	-10.74
Total Equity	980.39	882.77	809.80	738.74
Total Equity Growth (%)	11.06	9.01	9.62	7.94
Current Ratio (x)	2.68	1.36	1.50	2.28
Total Debt to Equity (x)	0.55	0.19	0.13	0.02
Contingent Liabilities	0.00	128.35	23.28	3.65

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	1,818.45	1,283.31	1,171.57	909.38	877.06
Total Assets Growth (%)	41.70	9.54	28.83	3.69	45.08
Total Liabilities	826.54	390.01	356.32	166.88	190.31
Total Liabilities Growth (%)	111.93	9.45	113.52	-12.31	-48.93
Total Equity	991.91	893.30	815.24	742.50	686.75
Total Equity Growth (%)	11.04	9.58	9.80	8.12	-
Current Ratio (x)	2.82	1.40	1.53	2.38	2.28
Total Debt to Equity (x)	0.54	0.19	0.13	0.02	0.04
Contingent Liabilities	0.00	128.35	79.79	3.65	3.65

All figures in Rs Cr, unless mentioned otherwise

Annual	FY 2026	FY 2025	FY 2024	FY 2023
Net Cash flow from Operating Activities	143.10	87.33	24.35	76.30
Net Cash used in Investing Activities	-395.99	-99.61	-128.88	-108.89
Net Cash flow from Financing Activities	279.27	13.75	84.19	-33.15
Net Cash Flow	26.38	1.47	-20.35	-65.73
Closing Cash & Cash Equivalent	30.22	3.85	2.38	22.72
Closing Cash & Cash Equivalent Growth (%)	685.80	61.94	-89.55	-74.31
Total Debt/ CFO (x)	3.73	1.90	4.38	0.22

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash flow from Operating Activities	134.11	89.38	24.39	75.48	128.71
Net Cash used in Investing Activities	-390.80	-101.83	-128.88	-108.54	-241.10
Net Cash flow from Financing Activities	278.42	13.91	84.21	-33.13	176.04
Net Cash Flow	21.73	1.46	-20.27	-66.19	63.65
Closing Cash & Cash Equivalent	25.05	3.32	1.86	22.13	88.32
Closing Cash & Cash Equivalent Growth (%)	655.34	78.47	-91.60	-74.94	257.95
Total Debt/ CFO (x)	3.96	1.85	4.37	0.22	0.20

All figures in Rs Cr, unless mentioned otherwise

Insights

Increase in Cash from Investing
Company has used Rs 395.99 cr for investing activities which is an YoY increase of 297.54%. (Source: Consolidated Financials)

Annual	FY 2026	FY 2025	FY 2024	FY 2023
Return on Equity (%)	10.34	8.79	7.01	8.40
Return on Capital Employed (%)	10.64	13.04	9.71	10.84
Return on Assets (%)	5.56	6.05	4.84	6.82
Interest Coverage Ratio (x)	7.43	8.75	9.77	18.41
Asset Turnover Ratio (x)	0.50	0.58	0.60	0.55
Price to Earnings (x)	16.67	32.68	34.97	23.31
Price to Book (x)	1.72	2.87	2.45	1.96
EV/EBITDA (x)	7.30	12.21	12.66	9.55
EBITDA Margin (%)	33.03	30.07	25.98	29.08

Annual	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Return on Equity (%)	10.35	9.26	7.18	8.55	10.29
Return on Capital Employed (%)	10.69	13.63	9.87	11.03	14.81
Return on Assets (%)	5.64	6.45	4.99	6.98	8.06
Interest Coverage Ratio (x)	7.54	9.05	9.90	18.70	8.08
Asset Turnover Ratio (x)	0.45	0.56	0.57	0.52	0.61
Price to Earnings (x)	16.47	30.67	34.01	22.78	21.60
Price to Book (x)	1.70	2.84	2.44	1.95	2.22
EV/EBITDA (x)	7.29	11.85	12.51	9.42	8.75
EBITDA Margin (%)	37.05	32.61	27.61	30.95	32.85

Found Financials useful?

Share Price Forecast

Exclusively for ETPrime

REVENUE
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
EARNINGS
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP
PRICE
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
READ FOR FREE ON APP

Technicals

Buy/Sell Signals
No Data Available
Price Analysis
No Data Available
Pivot Levels
R1 - Pivot
-
S1 -
R2 - S2 -
R3 - S3 -
Average True Range
5 Days 14 Days 28 Days
- - -

Peer Comparison

Ratio Performance

NAME	P/E (x)	P/B (x)	ROE %	ROCE %	ROA %	Rev CAGR [3Yr]	OPM	NPM	Basic EPS	Current Ratio	Total Debt/ Equity (x)	Total Debt/ CFO (x)
Krsnaa Diagnostics	17.05	1.76	10.34	10.64	5.56	17.05	21.32	13.13	31.29	2.68	0.55	3.73
Dr Lal Pathlabs	52.89	10.51	20.12	26.78	16.04	11.51	26.13	18.45	30.24	3.48	0.00	0.00
Vijaya Diagnostic	76.20	13.75	18.07	19.22	11.47	20.60	32.65	21.24	16.81	2.60	0.00	0.00
Metropolis Health	56.75	7.07	12.55	16.22	8.88	12.70	17.78	11.61	9.19	1.40	0.01	0.05
Thyrocare Tech.	50.71	14.11	27.84	34.59	21.81	16.32	26.59	19.47	10.27	3.39	0.00	0.00
Add More

Annual Ratios (%)

Choose from Peers

Choose from Stocks

Stock Performance

CHART
TABLE

1D
1W
1M
3M
6M
1Y
5Y

Choose from Peers
Choose from Stocks

Shareholding Pattern

Total Shareholdings
Category No. of Shares Percentage % Change QoQ
Promoters 87,95,605 27.11 % 0.00
Pledge 0 0.00 % 0.00
FII 12,67,981 3.91 % -0.25
DII 45,06,787 13.89 % 0.04
MF 33,00,139 10.17 % 0.01
Others 1,78,68,299 55.09 % 0.22
QoQ Change
Category Mar 2026 Dec 2025 Sep 2025 Jun 2025
Promoters 27.11 27.11 27.11 27.11
Pledge 0.00 0.00 0.00 0.00
FII 3.91 4.17 3.65 3.40
DII 13.89 13.85 14.96 14.24
Mutual Funds 10.17 10.15 10.46 9.63
Others 55.09 54.87 54.28 55.25

Mutual Funds Ownership

MF Ownership as on 30 April 2026

Tata Small Cap Direct-G
Equity: Small Cap
2
- 153.55
  Amount Invested (in Cr.)
- 1.36%
  % of AUM
- 0.00
  % Change (MoM basis)
Bandhan Small Cap Direct-G
Equity: Small Cap
5
- 37.74
  Amount Invested (in Cr.)
- 0.15%
  % of AUM
- 0.00
  % Change (MoM basis)
Shriram Multi Sector Rotation Direct-G
Equity: Thematic
- 2.60
  Amount Invested (in Cr.)
- 1.52318841%
  % of AUM
- 0.00
  % Change (MoM basis)

View all Mutual Fund Schemes

Krsnaa Diagnostics Top Searches

Corporate Actions

Recent
Board Meeting
Quarterly Results
Jan 28, 2026
Board Meeting
Quarterly Results
Oct 29, 2025
General Meeting
-
Aug 12, 2025

Announced on	Meeting on
Jan 28, 2026	Feb 05, 2026
Quarterly Results
Oct 29, 2025	Nov 07, 2025
Quarterly Results
Aug 04, 2025	Aug 11, 2025
Quarterly Results
May 05, 2025	May 12, 2025
Audited Results & Final Dividend
Feb 05, 2025	Feb 12, 2025
Quarterly Results

Dividends
Announced on Ex-Date Dividend%
May 12, 2025 Sep 12, 2025 55%
May 21, 2024 Sep 13, 2024 50%
May 29, 2023 Sep 15, 2023 55%
May 30, 2022 Sep 15, 2022 50%
Bonus
No Data Available
Splits
No Data Available
Rights
No Data Available

AGM/EGM Meetings

Announced on	Meeting on
Aug 12, 2025	Sep 25, 2025
-
Mar 11, 2025	Apr 13, 2025
-
Aug 07, 2024	Sep 21, 2024
Book closure from Sep 14, 2024 to Sep 21, 2024
Mar 05, 2024	Apr 07, 2024
-
Aug 14, 2023	Sep 25, 2023
Rs.2.7500 per share(55%)Final Dividend & A.G.M.

About Krsnaa Diagnostics

Krsnaa Diagnostics Ltd., incorporated in the year 2010, is a Small Cap company (having a market cap of Rs 1,734.82 Crore) operating in Hospitals & Allied Services sector.

Krsnaa Diagnostics Ltd. key Products/Revenue Segments include Hospital Services for the year ending 31-Mar-2025.

For the quarter ended 31-03-2026, the company has reported a Consolidated Total Income of Rs 224.10 Crore, up 21.16 % from last quarter Total Income of Rs 184.97 Crore and up 17.66 % from last year same quarter Total Income of Rs 190.46 Crore. Company has reported net profit after tax of Rs 41.72 Crore in latest quarter.

The company’s top management includes Mr.Rajendra Mutha, Mr.Yash Mutha, Mr.Mitesh Dave, Ms.Pallavi Bhatevara, Mr.Prem Pradeep, Mr.Adesh Kumar Gupta, Mr.Chetan Desai, Ms.Chhaya Palrecha, Mr.Rajiva Ranjan Verma, Mr.Pawan Daga, Mr.Sujoy Sudipta Bose. Company has MSKA & Associates as its auditors. As on 31-03-2026, the company has a total of 3.24 Crore shares outstanding.

Krsnaa Diagnostics Share Price Today is Rs. 533.10. On previous day, the Krsnaa Diagnostics Share Price (NSE) closed at Rs. 544.35, featuring among the most traded securities on the National Stock Exchange.

Shareholdings:
As of 31st Mar, 2026, the promoter held 27.11% of the stake in Krsnaa Diagnostics shares, out of which 0.0% was pledged. On the same date, foreign institutional investors' (FII) holdings of Krsnaa Diagnostics stocks was 3.91% as compared to 4.17% in Dec 2025 with decrease of 0.26%. The domestic institutional investors (DII) holdings on 31st Mar, 2026 was 13.89% as compared to 13.85% in Dec 2025 with increase of 0.04%. Out of the total DII holdings in Krsnaa Diagnostics shares 10.17% was held by mutual funds. The rest including public held is 55.09%. Krsnaa Diagnostics stock price is reflected on both the exchanges - BSE and NSE.

Dividend, Bonus & Split Information:
Krsnaa Diagnostics Dividend: Ever since 2010, Krsnaa Diagnostics dividends has been paid out around 5 times. As on 11 Jun, 2026, 03:57 PM IST, The overall dividend yield for Krsnaa Diagnostics stands at 0.0%. The last dividend paid was on September 12, 2025 (Rs. 2.75). The Earnings Per Share (EPS) for quarter ending 31st Mar 2026 is Rs. 31.27.

Krsnaa Diagnostics Bonus: The most recent bonus issue had been in year null around 0 years ago at 0 : 0 ratio. The first bonus issue was announced in null.

Stock Forecast:
After showing 224.1 Cr. of sales and 21.16% of quarterly net profit, there have been multiple ups and downs in the Krsnaa Diagnostics stock prices in the past few weeks. For example, Krsnaa Diagnostics stock price on 3rd of June 2026 was around Rs. 541.0. Krsnaa Diagnostics share price now stands at an average of Rs. 533.10. Judging by last week's performance, stock is in up trend.

Krsnaa Diagnostics has a median target price of Rs. 825.0 in 12 months by 3 analysts. They have provided a high estimate of Rs. 960.0 and low estimate of Rs. 682.0 for Krsnaa Diagnostics share.

Historical Prices and Performance:
Krsnaa Diagnostics, incorporated in 2010 is a Small Cap company (with a market cap of Rs. 1734.82) operating in Hospitals & Allied Services sector.
The Return of Equity (ROE) in last five financial years given by Krsnaa Diagnostics stock was 10.34%, 8.79%, 7.01%, 8.4% and 9.99% respectively.
The Krsnaa Diagnostics share gave a 3 year return of -5.6% as compared to Nifty 50 which gave a return of 25.06%.
Krsnaa Diagnostics announced 55.0% final dividend on September 12, 2025.

Key Metrics:
PE Ratio of Krsnaa Diagnostics is 17.1
Prices/Sales Ratio of Krsnaa Diagnostics is 2.19
Price/Book Ratio of Krsnaa Diagnostics is 1.77

Peer Insights:
Peers are businesses with comparable activities, buisness objectives and affiliation with a particular industry area. For Krsnaa Diagnostics, major competitors and peers include Dr Lal Pathlabs, Vijaya Diagnostic, Metropolis Health and Thyrocare Tech.. As of Dec 2025, the dividend yield of Krsnaa Diagnostics stands at 0.0% while Dr Lal Pathlabs, Vijaya Diagnostic, Metropolis Health and Thyrocare Tech. stand at 1.53%, 0.16%, 0.0% and 2.63% respectively. The PE ratio and PB Ratio of the company are among its competitors stand at 17.1 and 1.77 respectively.

Leadership of Krsnaa Diagnostics :
Pawan Daga is Chief Financial Officer
Sujoy Sudipta Bose is Co. Secretary & Compl. Officer
Mitesh Dave is Group Chief Executive Officer
Rajendra Mutha is Chairman & Wholetime Director
Yash Mutha is Managing Director
Pallavi Bhatevara is Whole Time Director
Adesh Kumar Gupta is Independent Director
Rajiva Ranjan Verma is Independent Director
Chetan Desai is Independent Director
Chhaya Palrecha is Independent Director
Prem Pradeep is Nominee Director

Show More

Industry

Key Indices Listed On

BSE SmallCap, BSE Healthcare, BSE AllCap, BSE Next 250 Microcap, BSE NEXT 500

Address

S.No. 243/A, Hissa No. 6,CTS No. 4519, 4519/1,Pune, Maharashtra - 411019

Contact

investors@krsnaa.in

http://www.krsnaadiagnostics.com

Executive Leadership

RM

Rajendra Mutha

Chairman & Wholetime Director

YM

Yash Mutha

Managing Director

MD

Mitesh Dave

Group Chief Executive Officer

PB

Pallavi Bhatevara

Whole Time Director

Show More

Auditors

MSKA & Associates

FAQs about Krsnaa Diagnostics share

1. What's Krsnaa Diagnostics share price today and what are Krsnaa Diagnostics share returns ?
Krsnaa Diagnostics share price is Rs 533.10 as on 11 Jun, 2026, 03:57 PM IST. Krsnaa Diagnostics share price is down by 0.32% based on previous share price of Rs 544.35. Krsnaa Diagnostics share price trend:
- Last 12 Months: Krsnaa Diagnostics share price moved down 22.36%
- Last 3 Years: Krsnaa Diagnostics Share price moved down by 5.90%
2. What are the returns for Krsnaa Diagnostics share?
Return Performance of Krsnaa Diagnostics Shares:
- 1 Week: Krsnaa Diagnostics share price moved down by 1.78%
3. What is 52 week high/low of Krsnaa Diagnostics share price?
In last 52 weeks Krsnaa Diagnostics share had a high price of Rs 894.40 and low price of Rs 515.00
4. What is the PE & PB ratio of Krsnaa Diagnostics?
The PE ratio of Krsnaa Diagnostics stands at 17.1, while the PB ratio is 1.77.
5. What's the market capitalization of Krsnaa Diagnostics?
Within the Hospitals & Allied Services sector, Krsnaa Diagnostics stock has a market cap rank of 26. Krsnaa Diagnostics has a market cap of Rs 1,729.31 Cr.

Top Gainers

As on 03:59 PM | 11 Jun 2026

Aegis Logistics

925.90

124.90 (15.60%)

111.45

8.52 (8.28%)

DOMS Industries

2,255.40

136.81 (6.46%)

Blue Jet Healthcare

498.45

28.70 (6.11%)

1,923.80

90.80 (4.96%)

Top Losers

As on 03:59 PM | 11 Jun 2026

Balkrishna Ind.

1,974.00

-109.20 (-5.25%)

1,133.10

-60.31 (-5.06%)

155.70

-7.93 (-4.85%)

166.91

-8.00 (-4.57%)

Adani Transmission

1,466.70

-68.90 (-4.49%)

Equity Quick Links

Top Gainers
Top Losers
Hourly gainers
Hourly losers
Sensex
Nifty
NSE
BSE

Midcap stocks
Smallcap stocks
Largecap stocks
Sensex
Nifty
NSE
BSE
MCX Live

More from Markets

IPO
Stock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.